MedTrace Logo

Urologic Lymphadenectomy in AMIGO

NCT05132283 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-10-24

No results posted yet for this study

Summary

This research study involves the use of two navigation systems, the 3D Slicer-based navigation system, and the Siemens Monaco systems, to simplify the complexity of image-guided lymphadenectomy procedures (surgery to remove one or more lymph nodes) in patients with urological cancer.

Conditions

  • Urologic Cancer
  • Lymph Node Metastasis

Interventions

DEVICE

3D Slicer

Navigational device used during surgery to locate abnormal lymph nodes.

DEVICE

Monaco

Navigational device used during surgery to locate abnormal lymph nodes.

Sponsors & Collaborators

Principal Investigators

  • Matthew Mossanen, MD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2025-08-26
Completion
2025-12-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05132283 on ClinicalTrials.gov